Nadim Hamzaoui

627 total citations
14 papers, 317 citations indexed

About

Nadim Hamzaoui is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Nadim Hamzaoui has authored 14 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Nadim Hamzaoui's work include Cancer Genomics and Diagnostics (6 papers), Genetic factors in colorectal cancer (6 papers) and Epigenetics and DNA Methylation (3 papers). Nadim Hamzaoui is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Genetic factors in colorectal cancer (6 papers) and Epigenetics and DNA Methylation (3 papers). Nadim Hamzaoui collaborates with scholars based in France, United States and Italy. Nadim Hamzaoui's co-authors include Eric Pringault, Aurélien de Reyniès, Sophie Kernéis, Élise Caliot, Ivan Graber, Stéphane Nancey, Driffa Moussata, Jacques Bienvenu, Bernard Flourié and Olivia Barreau and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Annals of the New York Academy of Sciences.

In The Last Decade

Nadim Hamzaoui

11 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadim Hamzaoui France	8	111	88	88	62	61	14	317
Melanie Beyer Germany	7	192 1.7×	139 1.6×	103 1.2×	57 0.9×	72 1.2×	9	426
K. Sasaki Japan	10	28 0.3×	56 0.6×	143 1.6×	81 1.3×	117 1.9×	28	403
Kathryn S. McKee United States	8	74 0.7×	70 0.8×	192 2.2×	187 3.0×	39 0.6×	12	457
Fatima Domenica Elisa De Palma Italy	12	109 1.0×	76 0.9×	199 2.3×	141 2.3×	30 0.5×	23	429
Guy Wayne Novotny Denmark	14	245 2.2×	157 1.8×	326 3.7×	37 0.6×	32 0.5×	26	528
Vassilis Samaras Greece	12	74 0.7×	53 0.6×	202 2.3×	116 1.9×	89 1.5×	15	437
Nahoko Tomonobu Japan	9	80 0.7×	33 0.4×	184 2.1×	104 1.7×	104 1.7×	24	350
Nikè V.J.A. Büller Netherlands	10	40 0.4×	102 1.2×	320 3.6×	143 2.3×	93 1.5×	12	533
Mathieu Darsigny Canada	9	59 0.5×	133 1.5×	217 2.5×	98 1.6×	67 1.1×	10	385
Young Joon Byun South Korea	9	77 0.7×	56 0.6×	324 3.7×	60 1.0×	72 1.2×	13	497

Countries citing papers authored by Nadim Hamzaoui

Since Specialization

Citations

This map shows the geographic impact of Nadim Hamzaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadim Hamzaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadim Hamzaoui more than expected).

Fields of papers citing papers by Nadim Hamzaoui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadim Hamzaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadim Hamzaoui. The network helps show where Nadim Hamzaoui may publish in the future.

Co-authorship network of co-authors of Nadim Hamzaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Nadim Hamzaoui. A scholar is included among the top collaborators of Nadim Hamzaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadim Hamzaoui. Nadim Hamzaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Jouinot, Anne, Nadim Hamzaoui, Olivier Huillard, et al.. (2025). Predisposition to prostate cancer and clinical implications in a real-life cohort. European Journal of Human Genetics. 33(9). 1163–1172.

Bottosso, Michele, Benjamin Verret, Olivier Caron, et al.. (2024). Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 8(8). e2400139–e2400139. 3 indexed citations

Guerrini‐Rousseau, Léa, Jane Merlevede, Felipe Andreiuolo, et al.. (2024). Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome. Neuro-Oncology Advances. 6(1). vdae120–vdae120.

Djerroudi, Lounes, Julien Masliah‐Planchon, Hervé J. Brisse, et al.. (2023). Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab. JCO Precision Oncology. 7(7). e2200627–e2200627. 4 indexed citations

Lebrun, Marine, Fabienne Prieur, Françoise Desseigne, et al.. (2021). A novel POLD1 pathogenic variant identified in two families with a cancer spectrum mimicking Lynch syndrome. European Journal of Medical Genetics. 65(2). 104409–104409.

Hamzaoui, Nadim, Flora Alarcon, Nicolas Leulliot, et al.. (2020). Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk prediction. Genetics in Medicine. 22(9). 1533–1541. 15 indexed citations

Rousseau, Benoı̂t, Ivan Bièche, Éric Pasmant, et al.. (2020). 526O High activity of nivolumab in patients with pathogenic exonucleasic domain POLE (edPOLE) mutated Mismatch Repair proficient (MMRp) advanced tumours. Annals of Oncology. 31. S463–S463. 23 indexed citations

Siegfried, Aurore, Carole Corsini, Delphine Bonnet, et al.. (2018). Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma. Familial Cancer. 18(2). 173–178. 25 indexed citations

Rhayem, Yara, Sérgio B. Sousa, Rossella Libé, et al.. (2013). Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion. European Journal of Endocrinology. 170(1). 151–160. 7 indexed citations

10.

Barreau, Olivia, Guillaume Assié, Bruno Ragazzon, et al.. (2012). Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 98(1). E174–E184. 90 indexed citations

11.

Zagani, Rachid, Nadim Hamzaoui, Wulfran Cacheux, et al.. (2009). Cyclooxygenase-2 Inhibitors Down-regulate Osteopontin and Nr4a2—New Therapeutic Targets for Colorectal Cancers. Gastroenterology. 137(4). 1358–1366.e3. 45 indexed citations

12.

Nancey, Stéphane, Nadim Hamzaoui, Driffa Moussata, et al.. (2007). Serum Interleukin-6, Soluble Interleukin-6 Receptor and Crohn’s Disease Activity. Digestive Diseases and Sciences. 53(1). 242–247. 47 indexed citations

13.

Hamzaoui, Nadim, Sophie Kernéis, Élise Caliot, & Eric Pringault. (2004). Expression and distribution of β1 integrins in in vitro-induced M cells: implications for Yersinia adhesion to Peyer's patch epithelium. Cellular Microbiology. 6(9). 817–828. 40 indexed citations

14.

Hamzaoui, Nadim & Eric Pringault. (1998). Interaction of Microorganisms, Epithelium, and Lymphoid Cells of the Mucosa‐Associated Lymphoid Tissue. Annals of the New York Academy of Sciences. 859(1). 65–74. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact